Esgic-plus and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Esgic-plus (acetaminophen; butalbital; caffeine) and Cymbalta (duloxetine hydrochloride). Common drug interactions include sinusitis among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people have when they take Esgic-plus and Cymbalta. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Esgic-plus?

Esgic-plus has active ingredients of acetaminophen; butalbital; caffeine. It is often used in migraine. eHealthMe is studying from 269 Esgic-plus users. Check the latest studies of Esgic-plus.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,974 Cymbalta users. Check the latest studies of Cymbalta.



On Aug, 01, 2026

30 people who take Esgic-plus and Cymbalta together, and have interactions are studied.

Esgic-plus and Cymbalta drug interactions.

What are the common drug interactions of Esgic-Plus and Cymbalta, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Suicide attempt
  3. Swollen tongue (swelling of tongue)
  4. Abdominal discomfort
  5. Accidental death
  6. Adjustment disorder with depressed mood
  7. Anoxic encephalopathy (brain damage due to lack of oxygen)
  8. Aortic valve incompetence
  9. Aphonia (inability to produce voice)
  10. Arrhythmia (irregular heartbeat)

male:

  1. Drug hypersensitivity

What are the common drug interactions of Esgic-Plus and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Aortic valve incompetence
  2. Blood albumin decreased
  3. Decreased appetite
  4. Dehydration (dryness resulting from the removal of water)
  5. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  6. Herpes simplex (herpes simplex is a common viral infection)
  7. Irritability
  8. Joint swelling
  9. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  10. Nausea (feeling of having an urge to vomit)

40-49:

  1. Adjustment disorder with depressed mood
  2. Anoxic encephalopathy (brain damage due to lack of oxygen)
  3. Aphonia (inability to produce voice)
  4. Arrhythmia (irregular heartbeat)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Decreased appetite
  8. Ear infection
  9. Haemorrhage (bleeding)
  10. Hypotension (abnormally low blood pressure)

50-59:

  1. Hospitalisation
  2. Hypersensitivity
  3. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  4. Myocardial ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased)
  5. Neuromyopathy (disease of both muscles and nerves)
  6. Osteoporosis (bones weak and more likely to break)
  7. Otitis media (inflammation of the middle ear)
  8. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  9. Self-injurious ideation
  10. Sinusitis (inflammation of sinus)

60+:

  1. Accidental death
  2. Pruritus (severe itching of the skin)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 15 people, 50.00%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 15 people, 50.00%
  3. Headache (pain in head): 3 people, 10.00%
  4. Thyroid Diseases: 2 people, 6.67%
  5. Restless Leg Syndrome (a powerful urge to move your legs): 2 people, 6.67%
  6. Quit Smoking: 2 people, 6.67%
  7. Platelet Disorder: 2 people, 6.67%
  8. Oedema Peripheral (superficial swelling): 2 people, 6.67%
  9. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.67%
  10. Fatigue (feeling of tiredness): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Esgic-plus and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Esgic-plus and Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Esgic-plus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Esgic-plus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cymbalta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; butalbital; caffeine and duloxetine hydrochloride (the active ingredients of Esgic-plus and Cymbalta, respectively), and Esgic-plus and Cymbalta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: